Skip to main content

Beneficial ownership — 13D / 13G

87,281 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Boston Partners RRC Range Resources Corp 13G/A 5.09% 4mo
Boston Partners WHD Cactus, Inc. 13G 6.44% 4mo
Boston Partners TBI TrueBlue, Inc. 13G/A 8.13% 4mo
BAILLIE GIFFORD & CO CPNG Coupang, Inc. 13G/A 4.8% 4mo
Barnard Stephen J AVO Mission Produce, Inc. 13G/A 6.2% 4mo
Boston Partners PAL Proficient Auto Logistics, Inc 13G/A 0.57% 4mo
FIDUCIARY MANAGEMENT INC /WI/ HAYW Hayward Holdings, Inc. 13G 5.4% 4mo
Sanders Capital, LLC ULTA Ulta Beauty, Inc. 13G 5.74% 4mo
BAILLIE GIFFORD & CO COUR Coursera, Inc. 13G/A 5.4% 4mo
MILLENNIUM MANAGEMENT LLC RXST RxSight, Inc. 13G/A 7.3% 4mo
Boston Partners MEOH Methanex Corp 13G 5.31% 4mo
BIGGER CAPITAL FUND L P CLPT ClearPoint Neuro, Inc. 13G/A 7.45% 4mo
Laurion Capital Management LP IMUX Immunic, Inc. 13G 6.06% 4mo
Boston Partners DDI DoubleDown Interactive Co., Ltd. 13G/A 6.66% 4mo
Gonzalez Luis A AVO Mission Produce, Inc. 13G/A 9.2% 4mo
Empery Asset Management, LP CLNN Clene Inc. 13G 7.17% 4mo
Boston Partners VVV Valvoline Inc 13G/A 5.17% 4mo
Empery Asset Management, LP CLRB Cellectar Biosciences, Inc. 13G 9.99% 4mo
Copeland Capital Management, LLC NSSC Napco Security Technologies, Inc 13G 5.65% 4mo
Ascent Partners Fund LLC PFSA Profusa, Inc. 13G/A 9.99% 4mo
HUB Cyber Security Ltd. EVFM Evofem Biosciences, Inc. 13D 9.99% 4mo
Medicxi Growth I LP CNTA Centessa Pharmaceuticals plc 13G/A 0% 4mo
FARALLON CAPITAL MANAGEMENT LLC ASMB Assembly Biosciences, Inc. 13G/A 8.1% 4mo
Alpha Capital Anstalt FABC Fabric.AI, Inc. 13G/A 8.41% 4mo
Ascent Partners Fund LLC OBAI Our Bond, Inc. 13G/A 9.99% 4mo
Lizzio Joseph Christopher SMTK SmartKem, Inc. 13G/A 1.62% 4mo
Van Berkom & Associates Inc. STVN Stevanato Group S.p.A. 13G 6% 4mo
Copeland Capital Management, LLC KFRC Kforce Inc 13G 5.18% 4mo
Boston Partners CTKB Cytek Biosciences, Inc. 13G 5.91% 4mo
BAILLIE GIFFORD & CO DNLI Denali Therapeutics Inc. 13G/A 7.5% 4mo
BAILLIE GIFFORD & CO ELF e.l.f. Beauty, Inc. 13G/A 11.9% 4mo
Empery Asset Management, LP LTRN Lantern Pharma Inc. 13G 9.99% 4mo
Copeland Capital Management, LLC EE Excelerate Energy, Inc. 13G 6.2% 4mo
UBS Group AG RDAC Rising Dragon Acquisition Corp. 13G 5.5% 4mo
Boston Partners ZBRA Zebra Technologies Corp 13G 5.45% 4mo
FARALLON CAPITAL MANAGEMENT LLC LQDA Liquidia Corp 13G/A 9.4% 4mo
Atlas Venture Fund XI, L.P. KRRO Korro Bio, Inc. 13D/A 4.9% 4mo
PSM Holdings LLC PROP Prairie Operating Co. 13G 8.6% 4mo
Radoff Bradley Louis RHEP Regional Health Properties, Inc 13G/A 10.4% 4mo
Boston Partners DDI DoubleDown Interactive Co., Ltd. 13G/A 6.66% 4mo
Bruce Bernstein XWEL XWELL, Inc. 13D 6.9% 4mo
Boston Partners USFD US Foods Holding Corp. 13G/A 7.86% 4mo
CK Life Sciences Int'l., (Holdings) Inc. RNAZ Transcode Therapeutics, Inc. 13D/A 83.9% 4mo
Radoff Bradley Louis GCO Genesco Inc 13D/A 4.3% 4mo
BAILLIE GIFFORD & CO BSP Bending Spoons S.p.A. 13G 15.2% 4mo
Space Summit Capital LLC EWAV East West Ave Acquisition Corp. 13G 10.9% 4mo
Saba Capital Management, L.P. ECAT BlackRock ESG Capital Allocation Term Trust 13D/A 15.88% 4mo
Dennis J. Wilson LULU lululemon athletica inc. 13D/A 8.4% 4mo
GAMCO INVESTORS, INC. ET AL MYE Myers Industries Inc 13D/A 0% 4mo
Martin Ryan Todd KUST Kustom Entertainment, Inc. 13D/A 0% 4mo